Elderberry for Coronavirus

N/A

Waitlist Available

Research Sponsored by Franklin Health Research

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 13 weeks

Summary

This trial is testing whether taking elderberry extract capsules can help improve immune health. The study involves people who might get upper respiratory issues like colds. The elderberry extract has natural compounds that could boost the immune system and help fight infections. Elderberry extract has been traditionally used to treat respiratory problems and has shown potential in reducing the duration and severity of colds and influenza.

Eligible Conditions

Coronavirus
Cold
Influenza
Flu
Common Cold

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 13 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~13 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 13 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Duration of Upper Respiratory Events

Incidence of Upper Respiratory Events

Incidence of Upper Respiratory Symptomatic Days

+1 more

Secondary study objectives

Cognitive Wellbeing

Duration of COVID-19

Duration of influenza

+7 more

Other study objectives

Adverse Events

Digestive Health

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Intervention ArmExperimental Treatment1 Intervention

Participants will receive a 13-week supply of ElderCraft® (European black elderberry extract standardized to 15% anthocyanins). Each capsule contains 300mg of extract; participants will take a total of two capsules each day.

Group II: Placebo ArmPlacebo Group1 Intervention

Participants will receive a 13-week supply of inert placebo capsules matched for polysaccharide content. Participants will take a total of two capsules each day.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Elderberry

2011

N/A

~80

Do I qualify?Apply below to find out